Teladoc Health, Inc. (TDOC)
After hours:
| Previous close | 32.74 |
| Open | 32.47 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 31.33 - 33.38 |
| 52-week range | 27.38 - 174.32 |
| Volume | |
| Avg. volume | 7,944,725 |
| Market cap | 5.317B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -43.42 |
| Earnings date | 25 Jul 2022 - 29 Jul 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 64.84 |
- Motley Fool
Down 77%, This Stock Is a Buy Right Now
Unfortunately for the company, its results did not live up to expectations. For comparison, the company's net loss per share during the first quarter of 2021 was $1.31. Further, the healthcare company lowered its guidance for the year.
- Motley Fool
Teladoc Is Down 65%. Is It Time to Buy?
Teladoc Health (NYSE: TDOC) shares have been on a pretty consistent losing streak since the start of the year. Teladoc now is down about 65% year to date. At the same time, the telemedicine giant has continued to report double-digit revenue growth and increases in visits in an overall growth environment.
- Motley Fool
Could This Healthcare Stock Be Berkshire Hathaway's Next Pick?
Would Teladoc (NYSE: TDOC) make a good fit for Berkshire (NYSE: BRK.A) (NYSE: BRK.B)? In this clip from "The Rank" on Motley Fool Live, recorded on April 25, Motley Fool contributor Zane Fracek makes the case for why he'd like to see Berkshire expand into healthcare and telemedicine given the growth opportunity ahead.
